Bridgeway Capital Management LLC raised its holdings in MultiPlan Co. (NYSE:MPLN - Free Report) by 73.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 76,193 shares of the company's stock after purchasing an additional 32,187 shares during the quarter. Bridgeway Capital Management LLC owned about 0.47% of MultiPlan worth $1,126,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also made changes to their positions in the company. Northern Trust Corp raised its holdings in shares of MultiPlan by 5.5% in the fourth quarter. Northern Trust Corp now owns 14,335 shares of the company's stock valued at $212,000 after buying an additional 747 shares during the last quarter. XTX Topco Ltd purchased a new stake in shares of MultiPlan in the fourth quarter valued at about $225,000. Oppenheimer & Co. Inc. purchased a new stake in shares of MultiPlan in the fourth quarter valued at about $292,000. Jane Street Group LLC boosted its holdings in MultiPlan by 14.4% in the 4th quarter. Jane Street Group LLC now owns 19,985 shares of the company's stock valued at $295,000 after purchasing an additional 2,512 shares in the last quarter. Finally, Walleye Capital LLC acquired a new position in MultiPlan during the 4th quarter worth approximately $359,000. 87.15% of the stock is owned by hedge funds and other institutional investors.
MultiPlan Price Performance
Shares of NYSE:MPLN traded up $0.14 on Wednesday, reaching $21.81. 122,871 shares of the company were exchanged, compared to its average volume of 116,963. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 21.73. The company has a 50-day moving average of $20.67 and a 200-day moving average of $16.30. MultiPlan Co. has a 1-year low of $4.80 and a 1-year high of $29.84. The firm has a market cap of $352.69 million, a price-to-earnings ratio of -0.23 and a beta of 0.13.
MultiPlan Profile
(
Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
See Also
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
